Mark E. Metzger

4.5k citations
89 papers · 3.9k · h-index 34

Impact in

  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Hemophilia Treatment and Research
  • Genetics top 1%
    • Virus-based gene therapy research
    • Hemoglobinopathies and Related Disorders
    • Mesenchymal stem cell research

Papers in

    • Hematopoietic Stem Cell Transplantation 32
    • Erythropoietin and Anemia Treatment 2
    • Hemophilia Treatment and Research 2
    • Virus-based gene therapy research 53
    • Mesenchymal stem cell research 2

Mark E. Metzger

89 papers receiving 3.8k citations

Peers

Mark E. Metzger
Comparison fields: 5 of 80
  • Hematology 1.2k
  • Genetics 1.9k
  • Virology 166
  • Genetics 225
  • Immunology 228
Replace Martijn H. Brugman with:
Martijn H. Brugman Netherlands
Matthew Paul McCormack Australia
Emmanuelle M. Six France
Robert Pawliuk United States
Estelle Morillon France
Christopher Baum Germany
Monica Doedens Canada
Thomas C. Reynolds United States
Samantha Scaramuzza Italy
Nabil Kabbara France
Mark E. Metzger relative to Martijn H. Brugman Netherlands Martijn H. Brugman's profile →
Citations per field
00.5×2×3×3.6×
Martijn H. Brugman · 1×
Citations per year

Countries citing papers authored by Mark E. Metzger

Since Specialization
Citations

This map shows the geographic impact of Mark E. Metzger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Metzger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Metzger more than expected).

Fields of papers citing papers by Mark E. Metzger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Metzger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Metzger. The network helps show where Mark E. Metzger may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Metzger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Metzger Line = papers co-authored together Mark E. Metzger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011221
2 1998219
3 2006165
4 2014147
5 2007145
6 2004143
7 1994133
8 1996129
9 2007129
10 1999109
11 2002109
12 1996103
13 2000101
14 200097
15 201297
16 200096
17 200188
18 200988
19 201485
20 201484

About Mark E. Metzger

Mark E. Metzger is a scholar working on Hematology, Genetics, Immunology, Genetics and Molecular Biology, having authored 89 papers that have together received 3.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (53 papers), Hematopoietic Stem Cell Transplantation (32 papers), Erythropoietin and Anemia Treatment (2 papers), Hemophilia Treatment and Research (2 papers), RNA Interference and Gene Delivery (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Mesenchymal stem cell research (2 papers) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Hematology (1.2k citations), Genetics (1.9k citations), Virology (166 citations), Genetics (225 citations) and Immunology (228 citations). Mark E. Metzger has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Robert E. Donahue, Cynthia E. Dunbar, Brian A. Agricola, John F. Tisdale, Stephanie E. Sellers, Aylin C. Bonifacino, Allen E. Krouse, Irvin S. Y. Chen, Peiman Hematti and Richard A. Morgan. Their work appears in journals such as Blood, Human Gene Therapy, Molecular Therapy, Gene Therapy and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact